Edwards Lifesciences Pre-Tax Profit Margin 2010-2024 | EW

Current and historical pre-tax profit margin for Edwards Lifesciences (EW) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Edwards Lifesciences pre-tax profit margin for the three months ending September 30, 2024 was .
Edwards Lifesciences Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $6.34B $1.74B 27.36%
2024-06-30 $6.23B $1.72B 27.61%
2024-03-31 $6.14B $1.61B 26.19%
2023-12-31 $6.01B $1.60B 26.63%
2023-09-30 $5.35B $1.52B 28.45%
2023-06-30 $5.42B $1.54B 28.40%
2023-03-31 $5.50B $1.73B 31.45%
2022-12-31 $5.38B $1.77B 32.83%
2022-09-30 $5.36B $1.68B 31.39%
2022-06-30 $5.36B $1.67B 31.15%
2022-03-31 $5.36B $1.75B 32.65%
2021-12-31 $5.23B $1.70B 32.52%
2021-09-30 $5.10B $1.68B 33.01%
2021-06-30 $4.93B $1.66B 33.60%
2021-03-31 $4.48B $0.94B 21.03%
2020-12-31 $4.39B $0.92B 20.90%
2020-09-30 $4.37B $0.88B 20.07%
2020-06-30 $4.32B $0.82B 18.86%
2020-03-31 $4.48B $1.25B 27.97%
2019-12-31 $4.35B $1.17B 26.84%
2019-09-30 $4.15B $0.85B 20.45%
2019-06-30 $3.97B $0.80B 20.08%
2019-03-31 $3.82B $0.78B 20.30%
2018-12-31 $3.72B $0.76B 20.46%
2018-09-30 $3.64B $1.09B 29.93%
2018-06-30 $3.55B $1.05B 29.61%
2018-03-31 $3.45B $1.01B 29.18%
2017-12-31 $3.44B $1.04B 30.14%
2017-09-30 $3.32B $0.91B 27.50%
2017-06-30 $3.23B $0.89B 27.37%
2017-03-31 $3.15B $0.85B 26.92%
2016-12-31 $2.96B $0.74B 24.87%
2016-09-30 $2.87B $0.70B 24.56%
2016-06-30 $2.74B $0.67B 24.43%
2016-03-31 $2.60B $0.64B 24.72%
2015-12-31 $2.49B $0.62B 24.98%
2015-09-30 $2.44B $0.59B 24.13%
2015-06-30 $2.43B $0.56B 22.99%
2015-03-31 $2.39B $1.23B 51.46%
2014-12-31 $2.32B $1.14B 49.27%
2014-09-30 $2.24B $1.11B 49.60%
2014-06-30 $2.13B $1.09B 51.20%
2014-03-31 $2.07B $0.40B 19.22%
2013-12-31 $2.05B $0.51B 25.02%
2013-09-30 $2.02B $0.53B 26.29%
2013-06-30 $1.97B $0.52B 26.57%
2013-03-31 $1.94B $0.49B 25.45%
2012-12-31 $1.90B $0.39B 20.43%
2012-09-30 $1.82B $0.34B 18.58%
2012-06-30 $1.78B $0.30B 16.98%
2012-03-31 $1.73B $0.29B 16.50%
2011-12-31 $1.68B $0.29B 16.97%
2011-09-30 $1.64B $0.29B 17.43%
2011-06-30 $1.58B $0.29B 18.64%
2011-03-31 $1.51B $0.29B 18.99%
2010-12-31 $1.45B $0.27B 18.52%
2010-09-30 $1.40B $0.26B 18.54%
2010-06-30 $1.38B $0.29B 20.88%
2010-03-31 $1.35B $0.29B 21.11%
2009-12-31 $1.32B $0.30B 22.98%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $41.870B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.062B 26.20
Intuitive Surgical (ISRG) United States $209.612B 96.16
Alcon (ALC) Switzerland $45.206B 30.25
IQVIA Holdings (IQV) United States $38.108B 20.48
IDEXX Laboratories (IDXX) United States $37.713B 43.16
DexCom (DXCM) United States $34.497B 51.95
Mettler-Toledo (MTD) United States $28.642B 32.97
Waters (WAT) United States $24.401B 36.08
STERIS (STE) Ireland $22.253B 25.33
SONOVA HOLDING (SONVY) Switzerland $20.160B 0.00
Hologic (HOLX) United States $14.774B 15.85
Fresenius Medical Care AG KGaA (FMS) Germany $14.260B 14.64
Globus Medical (GMED) United States $11.976B 30.33
Sysmex ADR (SSMXY) Japan $11.771B 36.91
Penumbra (PEN) United States $10.036B 98.31
Masimo (MASI) United States $9.638B 46.64
Glaukos (GKOS) United States $8.562B 0.00
Teleflex (TFX) United States $8.064B 12.86
Integer Holdings (ITGR) United States $4.726B 26.79
Inari Medical (NARI) United States $4.676B 0.00
PROCEPT BioRobotics (PRCT) United States $3.694B 0.00
Veracyte (VCYT) United States $3.371B 101.16
Nihon Kohden (NHNKY) Japan $2.700B 14.76
LivaNova (LIVN) United Kingdom $2.605B 15.04
TransMedics (TMDX) United States $2.467B 78.19
Tandem Diabetes Care (TNDM) United States $2.413B 0.00
Elekta AB (EKTAY) Sweden $2.332B 20.97
Integra LifeSciences Holdings (IART) United States $2.008B 10.49
Alphatec Holdings (ATEC) United States $1.620B 0.00
RxSight (RXST) United States $1.353B 0.00
Pulse Biosciences (PLSE) United States $1.340B 0.00
Artivion (AORT) United States $1.311B 86.86
OPKO Health (OPK) United States $1.106B 0.00
Paragon 28 (FNA) United States $1.088B 0.00
AxoGen (AXGN) United States $0.807B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.781B 13.27
IRadimed (IRMD) United States $0.778B 42.03
Mesa Laboratories (MLAB) United States $0.770B 16.83
SiBone (SIBN) United States $0.725B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.706B 0.00
Treace Medical Concepts (TMCI) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.574B 0.00
Delcath Systems (DCTH) United States $0.526B 0.00
ClearPoint Neuro (CLPT) United States $0.521B 0.00
Semler Scientific (SMLR) United States $0.463B 24.35
AngioDynamics (ANGO) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.438B 0.00
Tactile Systems Technology (TCMD) United States $0.412B 22.30
NeuroPace (NPCE) United States $0.408B 0.00
CVRx (CVRX) United States $0.357B 0.00
Accuray (ARAY) United States $0.277B 0.00
Inogen (INGN) United States $0.258B 0.00
Alpha Tau Medical (DRTS) Israel $0.226B 0.00
Anteris Technologies Global (AVR) Australia $0.222B 0.00
KORU Medical Systems (KRMD) United States $0.222B 0.00
Nevro (NVRO) United States $0.214B 0.00
Sight Sciences (SGHT) United States $0.138B 0.00
Rapid Micro Biosystems (RPID) United States $0.133B 0.00
LENSAR (LNSR) United States $0.126B 0.00
Hyperfine (HYPR) United States $0.125B 0.00
Spectral Diagnostics (EDTXF) Canada $0.118B 0.00
Neuronetics (STIM) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.100B 15.20
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
InspireMD (NSPR) Israel $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.061B 31.57
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Positron (POSC) United States $0.053B 0.00
Microbot Medical (MBOT) United States $0.044B 0.00
Baird Medical Investment Holdings (BDMD) $0.039B 0.00
Spectral AI (MDAI) United States $0.037B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.032B 0.00
WORK Medical Technology Group (WOK) China $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
NexGel (NXGL) United States $0.023B 0.00
DarioHealth (DRIO) United States $0.021B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Aspira Women's Health (AWH) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Tenon Medical (TNON) United States $0.005B 0.00
T2 Biosystems (TTOO) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00